Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

被引:722
作者
Yan, YK [1 ]
Melchart, M [1 ]
Habtemariam, A [1 ]
Sadler, PJ [1 ]
机构
[1] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
基金
英国惠康基金;
关键词
D O I
10.1039/b508531b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Our work has shown that certain ruthenium(II) arene complexes exhibit promising anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their frameworks provide considerable scope for optimising the design, both in terms of their biological activity and for minimising side-effects by variations in the arene and the other coordinated ligands. Initial studies on amino acids and nucleotides suggest that kinetic and thermodynamic control over a wide spectrum of reactions of Ru(II) arene complexes with biomolecules can be achieved. These Ru( II) arene complexes appear to have an altered profile of biological activity in comparison with metal-based anticancer complexes currently in clinical use or on clinical trial.
引用
收藏
页码:4764 / 4776
页数:13
相关论文
共 98 条
[21]  
Cleare MJ., 1973, BIOINORG CHEM, V2, P187, DOI [DOI 10.1016/S0006-3061(00)80249-5, https://doi.org/10.1016/S0006-3061(00)80249-5]
[22]   Cisplatin: From DNA damage to cancer chemotherapy [J].
Cohen, SM ;
Lippard, SJ .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 67, 2001, 67 :93-130
[23]   INVESTIGATIONS INTO THE ANTITUMOUR ACTIVITY OF ORGANOTIN COMPOUNDS .2. DIORGANOTIN DIHALIDE AND DIPSEUDOHALIDE COMPLEXES [J].
CROWE, AJ ;
SMITH, PJ ;
ATASSI, G .
INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1984, 93 (04) :179-184
[24]   Binding of organometallic ruthenium(II) and osmium(II) complexes to an oligonucleotide: A combined mass spectrometric and theoretical study [J].
Dorcier, A ;
Dyson, PJ ;
Gossens, C ;
Rothlisberger, U ;
Scopelliti, R ;
Tavernelli, I .
ORGANOMETALLICS, 2005, 24 (09) :2114-2123
[25]   Ruthenium red potently inhibits immune responses both in vitro and in vivo [J].
Dwyer, DS ;
Gordon, K ;
Jones, B .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (11) :931-940
[26]  
Elschenbroich C., 1992, ORGANOMETALLICS CONC
[27]   Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes [J].
Fernández, R ;
Melchart, M ;
Habtemariam, A ;
Parsons, S ;
Sadler, PJ .
CHEMISTRY-A EUROPEAN JOURNAL, 2004, 10 (20) :5173-5179
[28]   Bioorganometallic chemistry:: synthesis, structure, and molecular recognition chemistry of (η5-pentamethylcyclopentadienyl)-rhodium-DNA/RNA complexes in water [J].
Fish, RH .
COORDINATION CHEMISTRY REVIEWS, 1999, 185-6 :569-584
[29]   Bioorganometallic chemistry: Structural diversity of organometallic complexes with bioligands and molecular recognition studies of several supramolecular hosts with biomolecules, alkali-metal ions, and organometallic pharmaceuticals [J].
Fish, RH ;
Jaouen, G .
ORGANOMETALLICS, 2003, 22 (11) :2166-2177
[30]   Nickel-iron-sulfur active sites: Hydrogenase and co dehydrogenase [J].
Fontecilla-Camps, JC ;
Ragsdale, SW .
ADVANCES IN INORGANIC CHEMISTRY, VOL 47, 1999, 47 :283-333